He Xu X - OmicsDI

Show results for

Unknown (7787)
Proteomics (188)
Genomics (38)
Transcriptomics (37)
Metabolomics (28)
Multiomics (6)
Models (2)
Other (1)

Organisms

Homo sapiens (96)
Allexis (92)
Arabidopsis thaliana (92)
Callinectes sapidus (92)
Cyanophora paradoxa (92)
Mus musculus (33)
Rattus norvegicus (10)
Ovis aries (2)
Oryza sativa (2)
Rhodococcus opacus (1)
Hevea brasiliensis (1)
Siniperca chuatsi (1)
Clonorchis sinensis (1)
Zea mays (1)
Gallus gallus (1)
Drosophila melanogaster (1)
Homo sapiens x Mus musculus hybrid cell line (1)
Human parechovirus strain T82-0169 (1)
Macaca fascicularis fascicularis (1)
Mus (1)
Octocorallia (1)
Oreochromis aureus x Oreochromis niloticus (1)
Oreochromis niloticus niloticus (1)
Oryctolagus cuniculus (1)
Pseudomonas ogarae (1)
Pyricularia oryzae 70-15 (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Trichuris sp. ex Homo sapiens JP-2011 (1)
Triticum aestivum/Septoria tritici mixed cDNA library (1)
uncultivated soil bacterium (1)

Repository

pride (92)
iProX (80)
biostudies-arrayexpress (58)
MetaboLights (26)
EGA (17)
MassIVE (11)
PeptideAtlas (5)
BioModels (2)
GNPS (2)
GPMDB (1)

Tissue

Cell culture (19)
Liver (9)
Epithelial cell (8)
Brain (7)
Testis (7)
Permanent cell line cell (6)
Blood plasma (5)
Others (3)
Blood cell (3)
Colon (3)
Heart (3)
Macrophage (3)
Spleen (3)
Male Reproductive System (2)
B cell (2)
Blood serum (2)
Hepatocyte (2)
Kidney (2)
Lung (2)
Ovary (2)
Plant cell (2)
Primary cell (2)
Saliva (2)
Stem cell (2)
Urine (2)
Whole body (2)
Blood platelet (1)
Bone marrow (1)
Cell suspension culture (1)
Cerebrospinal fluid (1)

Disease

Disease free (6)
Colon cancer (4)
Cardiovascular system disease (3)
Breast cancer (2)
Hepatocellular carcinoma (2)
Stomach carcinoma (2)
Not Available (1)
Brain glioblastoma multiforme (1)
Cholangiocarcinoma (1)
Infantile hypotonia with psychomotor retardation and characteristic facies-3 (1)
Multiple myeloma (1)
Peripheral primitive neuroectodermal tumor (1)
Polycystic Kidney (1)
Severe acute respiratory syndrome (1)
Stomach cancer (1)
Type 2 diabetes mellitus (1)
Vascular dementia (1)

Technology Type

Mass Spectrometry (92)
Shotgun proteomics (51)
Mass spectrometry (22)
Bottom-up proteomics (10)
Affinity purification coupled with mass spectrometry proteomics (8)
Gel-based experiment (7)
Mass spectrometry assay (4)
SWATH MS (4)
Data-dependent acquisition (3)
Data-independent acquisition (3)
All-ion fragmentation (2)
SRM/MRM (2)
Top-down proteomics (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
MSE (1)
Mass spectrometry imaging (1)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (17)
Liquid Chromatography MS - positive - reverse phase (16)
Liquid Chromatography MS - positive - hilic (5)
Q Exactive HF (4)
MS:1000031 (3)
LTQ Orbitrap Velos (3)
Liquid Chromatography MS - negative - hilic (3)
Illumina NovaSeq 6000 (2)
TripleTOF 6600 (2)
Liquid Chromatography MS - - reverse phase (2)
LTQ Orbitrap Elite (2)
Hamamatsu Nanozoomer S60 (1)
Illumina HiSeq 2500 (1)
Instrument (1)
LTQ Orbitrap (1)
LTQ Orbitrap Velos Pro (1)
Q Exactive HF-X (1)
Liquid Chromatography MS - negative - reverse phase - LTQ-Orbitrap (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Gas Chromatography MS - positive (1)
Agilent 7890A+LECO Chroma TOF PEGASUS HT (1)
Liquid Chromatography MS - alternating - reverse phase (1)
QExactive (1)

Publication Date

2023 (33)
2025 (27)
2022 (24)
2021 (20)
2016 (18)
2024 (16)
2020 (15)
2014 (14)
2019 (13)
2026 (11)
2017 (11)
2015 (9)
2013 (9)
2012 (9)
2010 (6)
2018 (6)
2008 (2)
2005 (1)
2011 (1)
2009 (1)

UNIPROT ID/AC

A0A024R563 (5)
A0A024R8H9 (5)
A0A024RAN2 (5)
A0A024RC46 (5)
A0A087WVZ5 (5)
A0A087WXI0 (5)
A0A087X1S3 (5)
A0A0A0MS51 (5)
A0A0A0MSA7 (5)
A0A0C4DG89 (5)
A0AV96 (5)
A0AVT1 (5)
A0FGR8 (5)
A0FGR8-2 (5)
A0FGR8-6 (5)
A0MZ66 (5)
A0PJW6 (5)
A1L0T0 (5)
A1X283 (5)
A2BFH1 (5)
A2RRP1 (5)
A2RTX5 (5)
A3KN83 (5)
A4D110 (5)
A4D1P6 (5)
A4D1S5 (5)
A5A3E0 (5)
A5YKK6 (5)
A6NDG6 (5)
A6NDU8 (5)

ENSEMBL ID

ENSG00000170477 (5)
ENSG00000247315 (5)
ENSG00000147251 (4)
ENSG00000214897 (2)
ENSG00000229353 (2)
ENSG00000204131 (1)

CHEBI ID

CHEBI:15354 (11)
CHEBI:17295 (10)
CHEBI:55328 (9)
CHEBI:16704 (9)
CHEBI:17596 (9)
CHEBI:30769 (9)
CHEBI:46961 (8)
CHEBI:16196 (8)
CHEBI:16393 (8)
CHEBI:17568 (8)
CHEBI:17750 (8)
CHEBI:15891 (8)
CHEBI:17405 (8)
CHEBI:15971 (8)
CHEBI:16347 (8)
CHEBI:16828 (8)
CHEBI:17351 (8)
CHEBI:18344 (8)
CHEBI:17368 (8)
CHEBI:18132 (7)
CHEBI:16040 (7)
CHEBI:16708 (7)
CHEBI:28875 (7)
CHEBI:6650 (7)
CHEBI:16566 (7)
CHEBI:30763 (7)
CHEBI:16335 (7)
CHEBI:7916 (7)
CHEBI:16467 (7)
CHEBI:48131 (7)

Metabolite Name

Taurine (7)
Uridine (7)
Uracil (6)
Choline (6)
Citric acid (6)
L-Tryptophan (6)
Inosine (6)
Hypoxanthine (6)
LysoPC(15:0) (5)
Kynurenic acid (5)
L-Arginine (5)
Malic acid (5)
Adenosine (5)
Linoleic acid (5)
Azelaic acid (5)
Adenine (5)
Myristic acid (5)
L-Tyrosine (5)
Ethyl glucuronide (4)
LysoPE(0:0/18:0) (4)
Betaine (4)
Genistein (4)
Stearidonic acid (4)
Sphingosine (4)
Gingerol (4)
Phytosphingosine (4)
Methyl jasmonate (4)
Palmitoleic acid (4)
L-Histidine (4)
Cortisone (4)

IsPrivate

False (2)

Submitter Keywords

Immuno-oncology (1)

Modelling Approach

Ordinary differential equation model (2)

Study type

ChIP-seq (16)
Transcription profiling by array (16)
RNA-seq of coding RNA (14)
Methylation profiling by high throughput sequencing (5)
RNA-seq of non coding RNA (3)
Transcription profiling by tiling array (1)
Transcription profiling by RT-PCR (1)
Genotyping by high throughput sequencing (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2025 (1370)
2022 (1071)
2024 (1060)
2023 (1053)
2021 (815)
2020 (562)
2019 (357)
2018 (316)
2017 (292)
2016 (216)
2026 (178)
2015 (178)
2014 (133)
2013 (79)
2012 (61)
2011 (39)
2010 (28)
2009 (16)
2008 (7)
2005 (4)
2007 (3)
2002 (3)
2001 (2)
2006 (1)
2004 (1)

Lab affiliation

Beijing proteome research center (3)
State Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 102206, China (3)
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, N0. 1037 Luoyudong Road, Hongshan District, Wuhan 430074 (2)
Jiangnan University (2)
Key Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, No. 8, Longyuan Road, Nanshan District, Shenzhen, China 518055. (2)
Shanghai Center for Systems Biomedicine Shanghai Jiao Tong University (2)
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China (2)
State Key Lab of Reproductive Medicine, Nanjing Medical University (2)
Zhejiang University (2)
1)Chongqing Medical University;2) Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital (1)
BGI-shenzhen (1)
Basic Medicine, Guangxi University of Chinese Medicine, Nanning, China (1)
Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China (1)
Beijing Proteome Research Center, 38 Science Park Road, Changping District, Beijing 102206, China. (1)
Beijing proteome research center, Beijing, China (1)
Bio-X Institutes, Key Laboratory for the Genetics of Development and Neuropsychiatric Disorders (Ministry of Education), Shanghai Key Laboratory of Psychotic Disorders, and Brain Science and Technology Research Center, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China. (1)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1)
Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China (1)
Department of Biochemistry and Molecular Cell Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (1)
Department of Burns and Reconstructive Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. (1)
Department of Cancer Biology, Dana-Farber Cancer Institute Department of Cell Biology, Harvard Medical School (1)
Department of Chemistry, SUSTech (1)
Department of Chemistry, The University of Hong Kong (1)
Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University. (1)
Department of Human Anatomy, Histology, and Embryology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) and State Key Laboratory of Natural and Biomimetic Drugs,Peking University Health Science Center, Beijing 100191, China. (1)
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92037 United States (1)
Department of Pathophysiology, Key Laboratory of Ministry of Education for Neurological Disorders, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology (1)
Department of orthopaedics, the First Affiliated Hopital of Soochow University, Suzhou, China 215006 (1)
Dept.Pharmacology & Chemical Biology UPMC Hillman Cancer Center (1)
Dezhou University (1)

Previous page
1 / 809
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 809
Next page

Sort by:

Relevance

Page size

X-inactivation in hESCs

X chromosome inactivation (XCI) is a dosage compensation mechanism in female cells to regulate X-linked gene expression. We report here that subcultures from established lines of female hESCs displayed variations (0-100%) in the expression of XCI markers such as XIST RNA coating and enrichment of h...

ORGANISM(S): Homo sapiens

2010-05-26 | E-GEOD-9637 | biostudies-arrayexpress

Protocol for a parallel assignment prospective, randomised, double-blinded, placebo-controlled trial to evaluate the efficacy of 0.01% atropine for near work-induced transient myopia and myopic progression in China.

Not available

S-EPMC10748874 | biostudies-literature

One-step triplex reverse-transcription PCR detection of porcine epidemic diarrhea virus, porcine sapelovirus, and porcine sapovirus.

Not available

S-EPMC6900713 | biostudies-literature

Study on the Development and Formation Specifics of Longissimus Dorsi Muscles in Ziwuling Black Goats.

Not available

S-EPMC12649415 | biostudies-literature

Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome.

Not available

S-EPMC10465902 | biostudies-literature

Comparison of non-pharmaceutical treatments for evaporative dry eye: a randomised controlled study protocol.

Not available

S-EPMC10900569 | biostudies-literature

Genetic Evolution and Molecular Selection of the HE Gene of Influenza C Virus.

Not available

S-EPMC6409753 | biostudies-literature

Proteomics analysis of the membrane vesicles in Pseudomonas aeruginosa under X-ray irradiation

Pseudomonas aeruginosa, X-ray irradiation, inner membrane blebbing, membrane vesicles Almost all bacteria produce membrane vesicles (MVs) that have been found to be generally composed of lipopolysaccharides (LPSs), phospholipids (PLs), outer membrane proteins, periplasmic proteins and peptidoglycan ...

ORGANISM(S): Pseudomonas aeruginosa PAO1

2025-08-25 | PXD037062 | Pride

Relationship between ocular surface pain and corneal nerve loss in dry eye diabetics: a cross-sectional study in Shenyang, China.

Not available

S-EPMC10533686 | biostudies-literature

Analysis of the human adult urinary metabolome variations with age, body mass index and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. ('Sacurine' data set)

Urine metabolomics is widely used for biomarker research in the fields of medicine and toxicology. As a consequence, characterization of the variations of the urine metabolome under basal conditions becomes critical in order to avoid confounding effects in cohort studies. Such physiological infor...

2017-01-20 | MTBLS404 | MetaboLights

Previous page
1 / 809
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 809
Next page

Sort by:

Relevance

Page size

8081 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

IsPrivate

Submitter Keywords

Modelling Approach

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets